Literature DB >> 15794125

Topography and function of androgen-metabolizing enzymes in the central nervous system.

Yoshihiro Tsuruo1.   

Abstract

The present review describes concisely the topography and function of the three androgen-metabolizing enzymes, namely aromatase, 5alpha-reductase and 3alpha-hydroxysteroid dehydrogenase, in the central nervous system (CNS). Aromatase, estrogen synthetase, is the key enzyme for converting androgens to estrogens. Aromatase is indispensable for the sexual differentiation of the brain and the enzyme activity and expression of aromatase are high during the critical period of neural development, which extends from the late embryonal to the early neonatal period in rodents. Aromatase is expressed in neurons within specific hypothalamic and limbic regions. The locations of aromatase-immunoreactive neurons are divided into three groups according to the period of enzyme expression. Steroid 5alpha-reductase converts a number of steroids with a C3 ketone group and a C4-C5 double bond (delta4; androgens, progestins and glucocorticoids) to their 5alpha-reduced metabolites. Two isoforms of 5alpha-reductase are found and type 1 is predominant in neural tissues. The enzyme activity of 5alpha-reductase is found widely in the CNS and is high in white matter regions. The enzyme expression of 5alpha-reductase peaks during the late embryonic period. 3alpha-Hydroxysteroid dehydrogenase is the oxidoreductase that interconverts 3-ketosteroids to 3alpha-hydroxysteroids. Four isozymes have been found in humans and only one type has been found in rats. The enzyme converts 5alpha-reduced steroids (e.g. 5alpha-dihydroprogesterone) to tetrahydrosteroids (e.g. 3alpha,5alpha-tetrahydroprogesterone). The latter steroid is a potent stimulator of the GABA(A) receptor. The activity of 3alpha-hydroxysteroid dehydrogenase is high during the first 1-2 postnatal weeks, decreases with development and this enzyme is highly expressed in astrocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15794125     DOI: 10.1111/j.1447-073x.2005.00098.x

Source DB:  PubMed          Journal:  Anat Sci Int        ISSN: 1447-073X            Impact factor:   1.741


  5 in total

Review 1.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 2.  Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain.

Authors:  Ion G Motofei; David L Rowland; Mirela Manea; Simona R Georgescu; Ioana Păunică; Ioanel Sinescu
Journal:  Clin Drug Investig       Date:  2017-06       Impact factor: 2.859

Review 3.  The Sturm und Drang of anabolic steroid use: angst, anxiety, and aggression.

Authors:  Joseph G Oberlander; Leslie P Henderson
Journal:  Trends Neurosci       Date:  2012-04-18       Impact factor: 13.837

4.  Gestational or acute restraint in adulthood reduces levels of 5α-reduced testosterone metabolites in the hippocampus and produces behavioral inhibition of adult male rats.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Front Cell Neurosci       Date:  2012-12-18       Impact factor: 5.505

5.  Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley.

Authors:  Eric M Roberts; Paul B English; Judith K Grether; Gayle C Windham; Lucia Somberg; Craig Wolff
Journal:  Environ Health Perspect       Date:  2007-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.